Adagio Therapeutics annonce l’élargissement de la population de patients participant à l’essai clinique mondial de phase 2/3 de l’ADG20 pour la prévention de la COVID-19

WALTHAM, Massachusetts, 10 sept. 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., une société biopharmaceutique au stade clinique axée sur la découverte, le développement et la commercialisation de solutions à base d’anticorps pour les maladies infectieuses présentant un potentiel pandémique, a annoncé aujourd’hui que le Comité indépendant de surveillance des données […] Lire la suite »

Adagio Therapeutics kündigt Ausweitung der Patientenpopulation in der globalen klinischen Phase-II/III-Studie zu ADG20 für die COVID-19-Prävention an

WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das sich auf die Erforschung, Entwicklung und Vermarktung antikörperbasierter Lösungen für Infektionskrankheiten mit Pandemiepotenzial konzentriert, hat heute bekanntgegeben, dass das unabhängige Datenkontrollkomitee (Independent Data Monitoring Committee, IDMC) für die EVADE-Phase-II/III-Studie zu […] Lire la suite »

IAC States that Cape Verde Again Fails to Live Up to the Rule of Law

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) — The facts of the Saab case are clear and without dispute according to Sputnik media via their special report written by Sergio Pintado, https://mundo.sputniknews.com/20210909/extradicion-de-alex-saab-a-eeuu-haria-sonrojar-a-un-estudiante-de-derecho-1115885046.html The headline of the report is telling, “Alex Saab’s extradition to the United States would make a law student […] Lire la suite »

Платформа данных Delphix DevOps обеспечивает сертифицированную интеграцию SAP с SAP NetWeaver® и SAP S / 4HANA®

РЕДВУД, Калифорния, Sept. 10, 2021 (GLOBE NEWSWIRE) — Delphix, ведущая компания по обработке данных для DevOps, объявила сегодня о том, что платформа данных Delphix DevOps Data Platform 6.0 прошла сертификацию SAP как интегрированная с SAP NetWeaver® и SAP S / 4HANA®. Интеграции помогают организациям использовать Delphix для автоматического маскирования данных […] Lire la suite »

Delphix DevOps Data Platform erreicht SAP-zertifizierte Integration mit SAP NetWeaver® und SAP S/4HANA®

REDWOOD CITY, Kalifornien, Sept. 10, 2021 (GLOBE NEWSWIRE) — Delphix, das branchenführende Datenunternehmen für DevOps, gibt heute bekannt, dass die Delphix DevOps Data Platform 6.0 eine SAP-Zertifizierung für die Integration in SAP NetWeaver® und SAP S/4HANA® erhalten hat. Die Integrationen unterstützen Unternehmen dabei, mit Delphix Daten automatisch zu maskieren, um die […] Lire la suite »

Olives and Wine: Conagen Makes Accessible Antioxidant Hydroxytyrosol by Fermentation

Bedford, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Leveraging its robust phenolics platform, Conagen announced the expansion of the health ingredient portfolio of its commercial partner Blue California, with the successful scale-up and commercialization of the powerful natural antioxidant ingredient hydroxytyrosol. With its health-promoting properties, hydroxytyrosol is a phenylethanoid found […] Lire la suite »

GA-ASI Flies UAS in the Canadian Arctic

SAN DIEGO, Sept. 10, 2021 (GLOBE NEWSWIRE) — In a flight that originated from its Flight Test and Training Center (FTTC) near Grand Forks, N.D., General Atomics Aeronautical Systems, Inc. (GA-ASI) flew a company-owned MQ-9A “Big Wing” configured Unmanned Aircraft System north through Canadian airspace past the 78th parallel. A […] Lire la suite »

CBP Modifies Top Glove Finding: First Finding Modified in 27 Years

BALTIMORE, Sept. 10, 2021 (GLOBE NEWSWIRE) — The international law firm Benjamin L. England & Associates, LLC is very proud and pleased to announce obtaining the successful modification of a Customs and Border Protection (CBP) Finding that imposed a U.S. import ban on Top Glove Corporation Bhd’s disposable gloves manufactured in Malaysia due to forced labor concerns. […] Lire la suite »

Présentation des résultats financiers du 1er semestre 2021 d’Inventiva

Daix (France), le 10 septembre 2021 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, […] Lire la suite »

Inventiva’s 2021 First-Half Financial Results Presentation

Daix (France), September 10, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that its management team will host […] Lire la suite »

Amolyt Pharma to Host Key Opinion Leader Webinar and Discuss Results of Phase I Clinical Trial of AZP-3601 on Friday, October 1st at 10:00am ET

LYON, France and CAMBRIDGE, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) —  Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced that it will host a key opinion leader (KOL) webinar on AZP-3601, the Company’s lead product candidate for the potential treatment […] Lire la suite »

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced that the independent data monitoring committee (IDMC) for the EVADE Phase 2/3 trial of ADG20 for the […] Lire la suite »